Accelus Announces First Procedure Integrating Remi Robotic Navigation System, LineSider Spinal System, and FlareHawk Expandable Interbody Fusion Device Technologies

Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the successful completion of the first surgery integrating its Remi™ Robotic Navigation, LineSider® Spinal System, and FlareHawk® Expandable Interbody Fusion Device systems in one procedure. The case was performed by board-certified and dual-fellowship-trained neurosurgeon Dr. Tien V. Le in March 2022 in Brandon, Florida.

“Accelus’ Remi Robotic Navigation System with LineSider pedicle screws, in tandem with its FlareHawk interbody fusion system, were ideal for performing this case, as the patient was experiencing instability and compression of the nerve roots following a previous decompression surgery that necessitated intervention,” said Dr. Le. “The use of all three novel technologies enabled a seamless, minimally invasive approach, which allowed for smaller incisions and a less pronounced interbody insertion profile, minimizing the risk of nerve injury.”

Dr. Le is a leader in providing minimally invasive surgical solutions and was selected by Dr. Kevin Foley, surgeon designer of the Remi Robotic Navigation System, to the prestigious post-graduate Spine Neurosurgery Fellowship at Semmes-Murphey Neurologic & Spine Institute. Certified for the use of robotic-assisted spine surgery since 2013, Dr. Le has recently incorporated the Remi system into his spine fusion procedures to help navigate the placement of pedicle screws in a more precise and accurate manner.

“Given its small size and compact setup when compared to incumbent spinal robotic technologies, Remi is well suited to advance the standard of care for robotic spinal navigation and will play a pivotal role in robotic-assisted spinal surgery in the years to come,” Dr. Le added. “Robotic-assisted navigation augments the well-established benefits of minimally invasive spinal surgery, reduces radiation exposure to the surgeon and everyone else in the operating room, and allows for the accurate placement of pedicle screws in otherwise difficult anatomy that may not be well visualized using conventional techniques.”

The Remi platform provides robotic-assisted placement of the LineSider Spinal System, a low-profile, minimally invasive pedicle screw system utilizing extended tab technology. Dr. Le also used FlareHawk in this procedure and has performed approximately 100 FlareHawk cases to date. FlareHawk, Accelus’ flagship product, features proprietary multidirectional expansion technology, designed to minimize neural retraction during implant insertion.

“Since our inception, Accelus has been focused on designing products that reconcile the desire of spine surgeons for a minimally invasive approach with the need for maximum clinical results,” said Chris Walsh, CEO and Co-Founder of Accelus. “Successful outcomes from procedures such as Dr. Le’s recent groundbreaking surgery validate our mission, and we look forward to expanding our scope to a variety of surgical approaches that can be performed across several clinical settings, including ASCs, in the future.”


Accelus is committed to accelerating minimally invasive spine surgery through its enabling technology with broad accessibility to previously underserved markets. Established in 2021 through the combination of Integrity Implants and Fusion Robotics, the company is focused on providing its proprietary Adaptive Geometry™ technology with pragmatic and economical navigation and robotic solutions with broad clinical use in spine surgery. Learn more at www.accelusinc.com.

SourceAccelus

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”